Welcome to The Ammon-Pinizzotto Center for Women’s Mental Health at MGH.

Our Center, established in 1989, has been renamed following the generous gift from Carol Ammon and Dr. Marie Pinizzotto. These resources will be used to realize the overarching mission of the Center.

This website provides a range of current information including discussion of new research findings in women’s mental health and how such investigations inform day-to-day clinical practice. Despite the growing number of studies being conducted in women’s health, the clinical implications of such work are frequently controversial, leaving patients with questions regarding the most appropriate path to follow. Providing these resources to patients and their doctors so that individual clinical decisions can be made in a thoughtful and collaborative fashion dovetails with the mission of our Center.

LATEST FROM THE BLOG

Perinatal Depression: How Do We Define High Risk? (Part 2)

MGH Center for Women's Mental Health2019-03-20T20:43:34-04:00March 20th, 2019|

Several weeks ago, the US Preventive Services Task Force (USPSTF) issued recommendations that all pregnant and postpartum women should be evaluated in order […]

Dr. Marlene Freeman: MDedge Masterclass on Treating Bipolar Disorder in Women

MGH Center for Women's Mental Health2019-03-18T23:09:09-04:00March 19th, 2019|

In this podcast, Dr. Freeman discusses some of the challenges in treating with bipolar disorder during pregnancy and shares preliminary data on the […]

FDA is Expected to Approve Brexanolone for the Treatment of Postpartum Depression

MGH Center for Women's Mental Health2019-03-18T22:49:26-04:00March 18th, 2019|

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression […]

Weekly Roundup for MARCH 8, 2019: Recent Publications in Women’s Mental Health

MGH Center for Women's Mental Health2019-03-15T12:14:12-04:00March 10th, 2019|

This week another study highlights the importance of prenatal vitamins in reducing the risk of autism spectrum disorders (ASD). This study from Schmidt […]

VIEW ALL RECENT BLOG POSTS

The National
Pregnancy Registry
for Psychiatric Medications:

All pregnant women between the ages of 18-45 with a history of psychiatric illness are eligible to enroll in the registry.

LEARN MORE

MGH Perinatal Depression Scale Mobile App

Are you pregnant? Do you own a smart phone? Get the MGH Perinatal Depression Scale app.

LEARN MORE

RESEARCH STUDIES

A Neurosteroid Intervention for Menopausal and Perimenopausal Depession

Are you experiencing symptoms of menopause and feeling depressed or down? You may be eligible for a research study at Massachusetts General Hospital evaluating how a medication treats menopausal depression and other symptoms of menopause.

National Pregnancy Registry for Psychiatric Medications©

The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, stimulants, and atypical antipsychotics that many women take during pregnancy to treat a wide range of mood, anxiety, or psychiatric disorders.

TO PARTICIPATE CALL TOLL-FREE:

1-866-961-2388

MGH Postpartum Psychosis Project (MGHP3)

If you are a mother who has experienced an episode of postpartum psychosis within the past ten years, you could help us to better understand this disorder. Researchers at Massachusetts General Hospital’s (MGH) Ammon-Pinizzotto Center for Women’s Mental Health are announcing the launch of a new research study called the MGH Postpartum Psychosis Project (MGHP3).

VIEW ALL